XML 26 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Operating Activities      
Net income (loss) $ 356,711 $ (192,947) $ 35,338
Adjustments to reconcile net income (loss) to operating activities:      
Amortization, depreciation and write-offs 489,008 547,084 431,063
Stock-based compensation 363,107 191,612 133,177
Impairment of investments 27,953 0 0
Change in operating right-of-use asset 17,842 17,107 26,313
Amortization of debt issuance costs and discount 9,363 12,678 12,825
Impairment and loss in connection with sale of long-lived assets 0 127,892 0
Other 6,200 1,786 7,431
Changes in operating assets and liabilities:      
Accounts receivable (261,279) (174,829) (201,948)
Prepaid expenses and other current assets (12,280) (3,725) (97,324)
Other assets (121,688) (77,343) (45,938)
Accounts payable 98,574 3,479 98,612
Operating lease liabilities (18,612) (18,898) (26,854)
Accrued and other liabilities 92,754 (6,412) 3,063
Deferred revenue 13,857 (14,711) (13,907)
Net cash provided by operating activities 1,061,510 412,773 361,851
Investing Activities      
Acquisitions of businesses and intangible assets (63,899) (1,345,776) (1,210,549)
Purchase of investments and other (17,934) (66,342) (15,000)
Purchase of property and equipment (4,246) (662) (1,390)
Proceeds from sale of assets and other 8,250 41,312 12,009
Net cash used in investing activities (77,829) (1,371,468) (1,214,930)
Financing Activities      
Repurchases of common stock (1,153,593) (338,880) 0
Principal repayments of debt (497,994) (25,810) (719,810)
Payments of withholding taxes related to net share settlement (246,435) (27,535) 0
Payments of deferred acquisition costs (33,903) (124,184) (234,068)
Payments of licensed asset obligation (27,110) (17,374) (17,970)
Principal payments of finance leases (20,170) (24,083) (15,271)
Payments of debt issuance cost (4,655) 0 (14,941)
Proceeds from debt issuance 395,281 0 2,344,000
Proceeds from exercise of stock options 20,932 25,487 31,156
Proceeds from the issuance of common stock through ESPP 4,856 5,531 2,877
Proceeds from issuance of common stock in initial public offering, net of issuance costs as adjusted for cost reimbursement 0 0 1,745,228
Payments of related party notes 0 0 (11,655)
Net cash provided by (used in) financing activities (1,562,791) (526,848) 3,109,546
Effect of foreign exchange rate on cash, cash equivalents and restricted cash equivalents 778 (4,477) (3,198)
Net (decrease) increase in cash, cash equivalents and restricted cash equivalents (578,332) (1,490,020) 2,253,269
Cash, cash equivalents and restricted cash equivalents at beginning of the period 1,080,484 2,570,504 317,235
Cash, cash equivalents and restricted cash equivalents at end of the period 502,152 1,080,484 2,570,504
Supplemental non-cash investing and financing activities disclosures:      
Right-of-use assets acquired under finance leases 113,440 46,108 20,497
Right-of-use assets acquired under operating leases 6,471 7,105 6,130
Conversion of convertible securities to Class A common stock 0 0 392,170
Issuance of convertible securities related to acquisitions 0 0 342,170
Issuance of common stock and common stock warrants in connection with acquisitions 0 137,422 0
Acquisitions not yet paid 0 31,045 79,095
Assets acquired not yet paid 0 33,566 25,640
Proceeds from sale of long-lived assets not yet received 0 7,000 0
Settlement of bonus compensation through issuance of common stock 0 0 2,503
Accretion of interest on related party promissory notes 0 0 595
Supplemental disclosure of cash flow information:      
Cash paid for income taxes, net of refunds 75,433 86,264 90,616
Cash paid for interest $ 248,828 $ 165,959 $ 76,695